ArticleCureus2025
An Atypical Descending Variant of Guillain-Barré Syndrome With Bulbar Palsy, Autonomic Instability, and Delayed Colonic Pseudo-Obstruction: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyradiculoneuropathy that is the most common cause of acute flaccid paralysis worldwide. The classical form manifests as an ascending, symmetrical weakness, but atypical variants, including descending presentations, have been increasingly recognized. Such variants often pose diagnostic challenges and are associated with more severe disease and prolonged recovery. We describe a 70-year-old woman with well-controlled hypertension who presented with progressive dysphagia, pooling of saliva, and upper limb weakness. Clinical examination revealed bulbar dysfunction, areflexia in the upper limbs, and motor power in the upper limbs was markedly reduced to grade 1/5 on the Medical Research Council (MRC) scale, while lower limb strength was preserved. Within hours of admission, the weakness progressed to quadriplegia with respiratory distress, necessitating intubation and mechanical ventilation. Cerebrospinal fluid analysis demonstrated albumin cytological dissociation, and nerve conduction studies revealed changes consistent with GBS. Intravenous immunoglobulin was initiated but discontinued due to anaphylaxis; therapeutic plasma exchange was subsequently performed. The patient had marked cardiovascular lability and, after one month, acute colonic pseudo-obstruction (ACPO), which resolved with conservative management. Around the 40th day, she experienced complete left lung collapse due to mucus plugging, which was successfully managed with bedside bronchoscopy. Persistent bulbar dysfunction delayed decannulation until day 80. Remarkably, full neurological recovery was achieved only after six months of follow-up. This case highlights several atypical and severe features of GBS: descending onset with bulbar involvement at presentation, multisystem autonomic dysfunction extending to the gastrointestinal tract, and a protracted course despite early immunotherapy and supportive care. The unusually delayed onset of ACPO and persistent bulbar palsy underscores the need for vigilance beyond the acute phase. Hence, clinicians should maintain a high index of suspicion for atypical variants of GBS in patients with acute, progressive weakness, even when the presentation deviates from the classical ascending pattern. A structured, multimodal diagnostic approach and timely initiation of therapy are essential to prevent complications. Severe variants may follow a prolonged recovery trajectory, requiring sustained multidisciplinary management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.